Advertisement

Topics

FUJIFILM Holdings Corporation Company Profile

14:33 EDT 26th July 2017 | BioPortfolio

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 25 companies around the world granted U.S. patents in 2009, and in the year ended March 31, 2009, had global revenues of $25 billion. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.


News Articles [616 Associated News Articles listed on BioPortfolio]

Fujifilm ramps up biosimilars production as UK court allows Humira biosimilar

A UK court has ruled in the favour of Japan-based Fujifilm Kyowa Kirin Biologics’ Humira biosimilar. The Fujifilm corporation has also announced a multi-million-dollar investment in its biologicals ...

Fujifilm Invests $130M to Expand U.S. and U.K. BioCDMO Business

Fujifilm says it is investing JPY14 billion ($130 million) to expand capacity at its U.S. and U.K.-based BioCDMO (biopharma contract development manufacturing operation) facilities. Fujifilm esta...

Fujifilm’s PACS gets go-ahead from Defense Department

The U.S. Department of Defense has given Fujifilm’s Synapse PACS the green light to operate on the department’s networks, granting the company an Authority to Operate (ATO) and making it the first...

FUJIFILM KYOWA KIRIN BIOLOGICS gibt Annahme des Antrags auf Marktzulassung für FKB327 zur Prüfung durch die Europäische Arzneimittelagentur bekannt

FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. (President und CEO: Hideaki Nomura; "Fujifilm Kyowa Kirin Biologics") gibt bekannt, dass die Europäische Arzneimittel-Agentur (EMA) am 18. Mai 2017 den Ant...

Fujifilm invests $130m in CDMO business, ups mammlian bioreactor capacity 70%

Fujifilm has invested around $130m into facilities in the US and UK weeks after launching its biopharma CDMO business.

GE Healthcare installs purification tech at FujiFilm Diosynth site

GE Healthcare has completed another tech installation at FujiFilm Diosynth’s biopharmaceuticals facility in Billingham, UK, integrating a single-use purification system with bioreactors it provided ...

FUJIFILM KYOWA KIRIN BIOLOGICS Announces Marketing Authorisation Application for FKB327 Accepted for Review by European Medicines Agency

Monday, May 22nd 2017 at 6:30am UTC TOKYO–(BUSINESS WIRE)– FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. (President & CEO: Hideaki Nomura; “Fujifilm Kyowa Kirin Biologics”) announces th...

ED-530XT Duodenoscopes by Fujifilm: Safety Communication - Recall Issued, Updated Design and Labeling

Audience: Gastroenterology, Risk Manager [Posted 07/21/2017] ISSUE: On July 21, 2017, Fujifilm issued an Urgent Medical Device Correction and Removal notification informing customers of its voluntary...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Case-control study on the use of pituitary-derived hormones from sheep as a potential risk factor for the occurrence of atypical scrapie in Great Britain.

A case-control study was conducted in 2013 to investigate the use of pituitary-derived hormones from sheep as a potential risk factor for the presence of atypical scrapie in Great Britain sheep holdin...

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research.

While significant medical breakthroughs have been achieved through using animal models, our experience shows that often there is surplus material remaining that is frequently never revisited but could...

Modelling virus coinfection to inform management of maize lethal necrosis in Kenya.

Maize lethal necrosis (MLN) has emerged as a serious threat to food security in sub-Saharan Africa. MLN is caused by coinfection with two viruses, maize chlorotic mottle virus (MCMV) and a potyvirus, ...

Linked color imaging enhances gastric cancer in gastric intestinal metaplasia.

Gastric intestinal metaplasia (GIM) is a high risk for intestinal type gastric cancer; however, there is a limitation for detection of GIM using white light imaging (WLI). Image-enhanced endoscopy (IE...

Impact of genetic variation on three dimensional structure and function of proteins.

The Protein Data Bank (PDB; http://wwpdb.org) was established in 1971 as the first open access digital data resource in biology with seven protein structures as its initial holdings. The global PDB ar...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training Program

The purpose of this pilot is to assess the adequacy of the Fujifilm DBT Reader Study Training program to ensure that Readers participating in the Fujifilm DBT pivotal trial are properly tr...

A Multi-Reader Multi-Case Pivotal Trial

The purpose of this pivotal reader study is to assess the comparative accuracy of Fujifilm FFDM plus DBT versus FFDM alone in the detection of breast cancer.

Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions

The newly developed linked color imaging (LCI) system (FUJIFILM Co.) creates clear and bright endoscopic images by using short-wavelength narrow-band laser light combined with white laser ...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Companies [593 Associated Companies listed on BioPortfolio]

FUJIFILM Corporation

FUJIFILM Corporation is one of the major operating companies of FUJIFILM Holdings. Since its founding in 1934, the company has built up a wealth of advanced technologies in the fi...

FUJIFILM Diosynth Biotechnologies U.S.A. Inc.

“Healthcare business, above all, the pharmaceutical business, is one of Fujifilm's focal areas,” said Shigehiro Nakajima, President & COO, FUJIFILM Holdings Corporation....

Merck and FUJIFILM Corporation

FUJIFILM Corporation is one of the major operating companies of FUJIFILM Holdings. Since its founding in 1934, the company has built up a wealth of advanced technologies in the fi...

FUJIFILM Holdings Corporation

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical...

FUJIFILM Medical Systems U.S.A., Inc.

FUJIFILM Medical Systems U.S.A., Inc. offers the industry's most extensive line of CR and DR products including single and multi-plate CR, digital portable systems, dual detector room replacements, an...

More Information about "FUJIFILM Holdings Corporation" on BioPortfolio

We have published hundreds of FUJIFILM Holdings Corporation news stories on BioPortfolio along with dozens of FUJIFILM Holdings Corporation Clinical Trials and PubMed Articles about FUJIFILM Holdings Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FUJIFILM Holdings Corporation Companies in our database. You can also find out about relevant FUJIFILM Holdings Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record